Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

DTIL US Equity

Precision Biosciences IncHealth Care · Biological Products, (No Diagnostic Substances) · CIK 1357874 · FY ends May 21
$8.50
+0.27 (+3.28%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2913G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Empery Asset Management, LPsec.gov ↗
2026-07-278-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-278-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-2013GSchedule 13G filed — ≥5% beneficial owner (passive) · by Lynx1 Capital Management LPsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-20

Every row is a filed document, checked against its EDGAR index.